Eyegene Inc.

This study is testing a new vaccine designed to protect against four types of meningococcal bacteria, which can cause serious brain and blood infections. It will involve about 1,123 healthy adults aged 19-55. Researchers will compare the new vaccine's safety and how well it trigg…